As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...] …
Blog Posts
SPONSORED CONTENT
The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is misused by covered entities (CEs) to generate profits rather than help vulnerable patients. These criticisms often come from a misunderstanding of
…
The Idaho House yesterday unanimously passed a 340B provider reporting bill, shortly after state lawmakers introduced contract pharmacy access legislation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge has ruled that a major hospital advocacy group and two of its members can join the government [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A coalition of national and local hospital advocacy groups recently filed briefs in multiple federal lawsuits: One that supports the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Michigan Senate overwhelmingly approved a bill earlier today to prohibit drugmaker 340B contract pharmacy restrictions and place new reporting [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Utah House and South Dakota House both overwhelmingly voted yesterday to pass 340B contract pharmacy access legislation, sending those [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington D.C. dark money group with White House ties recently upped its attacks on 340B contract pharmacy access bills [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
State legislators in Indiana, West Virginia and Illinois are pushing separate measures to add new 340B provider reporting requirements, restrict [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.K.-based drug giant this week moved to add three specialty cancer treatment medications to its list of drugs subject [...] …